Voltron Therapeutics
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
575 5th Ave Fl 14, New York, New York, 1...Phone Number
(212) 953-4936Website
www.voltrontx.comRevenue
<$5 MillionIndustry
About Voltron Therapeutics
Voltron Therapeutics, Inc., a Delaware corporation, was founded in 2017 to lead and accelerate the development of the Vaccine and Immunotherapy Center (VIC), and the Massachusetts General Hospital's novel Self Assembling Vaccine technology in a variety of indications, including in Oncology and emerging Infectious Diseases. Voltron holds an exclusive worldwide license to this technology. With the work of the company's world class team of researchers and physicians, this technology has shown in certain pre-clinical studies initial proof of concept in two infectious diseases (Lassa Fever and Q Fever) as well as two oncology indications (Ovarian and HPV Related Cancers).Explore more
SIC Code 87,873NAICS Code 54,541Show moreVoltron Therapeutics Org Chart
Compare Similar Companies to Voltron Therapeutics
Compare insights from companies similar to Voltron Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Voltron Therapeutics Tech Stack
A closer look at the technologies used by Voltron Therapeutics
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Voltron Therapeutics
Sign Up For FreeTo access detailed company insights
Voltron Therapeutics, Inc., a Delaware corporation, was founded in 2017 to lead and accelerate the development of the Vaccine and Immunotherapy Center (VIC), and the Massachusetts General Hospital's novel Self Assembling Vaccine technology in a variety of indications, including in Oncology and emerging Infectious Diseases. Voltron holds an exclusiv... Read More